본문 바로가기
KERD
논문KCI 등재

Barrett Esophagus: When to Endoscope

Joshua Butt|Gabor Kandel
대한소화기내시경학회 (The Korean Society Of Gastrointestinal Endoscopy)|2014.01|Clinical Endoscopy|제47권 제1호|pp. 40-46

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

EpidemiologyMass screeningEndoscopyBarrett esophagus
주제분류내과학

초록

Increasing interest in identifying an effective strategy for decreasing the burden of esophageal adenocarcinoma (EAC) has been fuelled by the rising EAC rates worldwide, the morbidity associated with esophagectomy, and the development of endoscopic methods for curing early-stage EAC. In the face of this enthusiasm, however, we should be cautious about adopting an evidence-free approach to screening and one with unclear benefits and unclear costs to the community. The literature is increasingly recognizing that the value of traditional endoscopy for screening and surveillance of Barrett esophagus may be more limited than initially believed. A better understanding of the risk factors for Barrett esophagus and progression to dysplasia and a more individualized risk calculation will be useful in defining populations to consider for Barrett screening. The development of novel, nonendoscopic screening techniques and of less expensive endoscopic techniques holds promise for a cost-effective screening and surveillance method to curtail the increasing rates of EAC.

Abstract

Increasing interest in identifying an effective strategy for decreasing the burden of esophageal adenocarcinoma (EAC) has been fuelled by the rising EAC rates worldwide, the morbidity associated with esophagectomy, and the development of endoscopic methods for curing early-stage EAC. In the face of this enthusiasm, however, we should be cautious about adopting an evidence-free approach to screening and one with unclear benefits and unclear costs to the community. The literature is increasingly recognizing that the value of traditional endoscopy for screening and surveillance of Barrett esophagus may be more limited than initially believed. A better understanding of the risk factors for Barrett esophagus and progression to dysplasia and a more individualized risk calculation will be useful in defining populations to consider for Barrett screening. The development of novel, nonendoscopic screening techniques and of less expensive endoscopic techniques holds promise for a cost-effective screening and surveillance method to curtail the increasing rates of EAC.

참고문헌 (64)

  1. Corley DA, "Impact of endoscopic surveillance on mortality from Barrett’s esophagus-associated esophageal adenocarcinomas", Gastroenterology, 145, pp.312~319 (2013)
  2. Solaymani-Dodaran M, "Cause-specific mortality of people with Barrett’s esophagus compared with the general population:a population-based cohort study", Gastroenterology, 144, pp.1375~1383 (2013)
  3. Corley DA, "Surveillance and survival in Barrett’s adenocarcinomas: a population-based study", Gastroenterology, 122, pp.633~640 (2002)
  4. Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008", Int J Cancer, 127, pp.2893~2917 (2010)
  5. Enzinger PC, "Esophageal cancer", N Engl J Med, 349, pp.2241~2252 (2003)
  6. Lao-Sirieix P, "Screening for oesophageal cancer", Nat Rev Clin Oncol, 9, pp.278~287 (2012)
  7. Pennathur A, "Oesophageal carcinoma", Lancet, 381, pp.400~412 (2013)
  8. Kelsen DP, "Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer", N Engl J Med, 339, pp.1979~1984 (1998)
  9. Medical Research Council Oesophageal Cancer Working Group, "Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial", Lancet, 359, pp.1727~1733 (2002)
  10. Cunningham D, "Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer", N Engl J Med, 355, pp.11~20 (2006)
  11. Pennathur A, "Esophagectomy for T1esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy", Ann Thorac Surg, 87, pp.1048~1054 (2009)
  12. Zhang Y, "Epidemiology of esophageal cancer", World J Gastroenterol, 19, pp.5598~5606 (2013)
  13. Umar SB, "Esophageal cancer: epidemiology, pathogenesis and prevention", Nat Clin Pract Gastroenterol Hepatol, 5, pp.517~526 (2008)
  14. Oze I, "Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population", Jpn J Clin Oncol, 41, pp.677~692 (2011)
  15. Lin J, "Hot beverage and food intake and esophageal cancer in southern China", Asian Pac J Cancer Prev, 12, pp.2189~2192 (2011)
  16. Bosetti C, "Trends in oesophageal cancer incidence and mortality in Europe", Int J Cancer, 122, pp.1118~1129 (2008)
  17. Lepage C, "Continuing rapid increase in esophageal adenocarcinoma in England and Wales", Am J Gastroenterol, 103, pp.2694~2699 (2008)
  18. Pohl H, "The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence", J Natl Cancer Inst, 97, pp.142~146 (2005)
  19. Devesa SS, "Changing patterns in the incidence of esophageal and gastric carcinoma in the United States", Cancer, 83, pp.2049~2053 (1998)
  20. Armstrong RW, "Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992", Int J Epidemiol, 25, pp.941~947 (1996)
  21. Stavrou EP, "Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005", Med J Aust, 191, pp.310~314 (2009)
  22. Edgren G, "A global assessment of the oesophageal adenocarcinoma epidemic", Gut, 62, pp.1406~1414 (2013)
  23. Koppert LB, "The molecular biology of esophageal adenocarcinoma", J Surg Oncol, 92, pp.169~190 (2005)
  24. Jenkins GJ, "Genetic pathways involved in the progression of Barrett’s metaplasia to adenocarcinoma", Br J Surg, 89, pp.824~837 (2002)
  25. Reid BJ, "Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis", Nat Rev Cancer, 10, pp.87~101 (2010)
  26. Islami F, "Helicobacter pylori and esophageal cancer risk:a meta-analysis", Cancer Prev Res (Phila), 1, pp.329~338 (2008)
  27. Rajendra S, "Barrett’s oesophagus in Asians: are ethnic differences due to genes or the environment?", J Intern Med, 270, pp.421~427 (2011)
  28. Anderson LA, "Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study", World J Gastroenterol, 13, pp.1585~1594 (2007)
  29. Lagergren J, "Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma", N Engl J Med, 340, pp.825~831 (1999)
  30. Engel LS, "Population attributable risks of esophageal and gastric cancers", J Natl Cancer Inst, 95, pp.1404~1413 (2003)
  31. Wilson JM, "Principles and practice of mass screening for disease", Bol Oficina Sanit Panam, 65, pp.281~393 (1968)
  32. Ronkainen J, "Prevalence of Barrett’s esophagus in the general population: an endoscopic study", Gastroenterology, 129, pp.1825~1831 (2005)
  33. Kadri SR, "Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study", BMJ, 341, pp.c4372~ (2010)
  34. Rubenstein JH, "Age- and sex-specific yield of Barrett’s esophagus by endoscopy indication", Gastrointest Endosc, 71, pp.21~27 (2010)
  35. Rajendra S, "Ethnic differences in the prevalence of endoscopic esophagitis and Barrett’s esophagus: the long and short of it all", Dig Dis Sci, 49, pp.237~242 (2004)
  36. Kim JY, "Prevalence of Barrett’s esophagus in Korea", J Gastroenterol Hepatol, 20, pp.633~636 (2005)
  37. Azuma N, "Prevalence of Barrett’s esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett’s esophagus and esophageal adenocarcinoma in Japan", J Gastroenterol, 35, pp.583~592 (2000)
  38. 유승석, "건강진단검사 수진자에서 식도질환의 유병률", 대한소화기학회지, 50(5), pp.306~312 (2007), 대한소화기학회
  39. 최철영, "이차 병원 건강검진자의 바렛식도 유병률 및 분문부 장상피화생과의 비교 연구", 대한소화기학회지, 60(4), pp.219~223 (2012), 대한소화기학회
  40. Park JJ, "The prevalence of and risk factors for Barrett’s esophagus in a Korean population: a nationwide multicenter prospective study", J Clin Gastroenterol, 43, pp.907~914 (2009)
  41. Shaheen NJ, "Is there publication bias in the reporting of cancer risk in Barrett’s esophagus?", Gastroenterology, 119, pp.333~338 (2000)
  42. Inadomi JM, "Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis", Ann Intern Med, 138, pp.176~186 (2003)
  43. Desai TK, "The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis", Gut, 61, pp.970~976 (2012)
  44. Bhat S, "Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study", J Natl Cancer Inst, 103, pp.1049~1057 (2011)
  45. Hvid-Jensen F, "Incidence of adenocarcinoma among patients with Barrett’s esophagus", N Engl J Med, 365, pp.1375~1383 (2011)
  46. de Jonge PJ, "Risk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort study", Gut, 59, pp.1030~1036 (2010)
  47. Sikkema M, "Predictors for neoplastic progression in patients with Barrett’s Esophagus: a prospective cohort study", Am J Gastroenterol, 106, pp.1231~1238 (2011)
  48. Curvers WL, "Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated", Am J Gastroenterol, 105, pp.1523~1530 (2010)
  49. Wani S, "Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus", Gastroenterology, 141, pp.1179~1186 (2011)
  50. Coleman HG, "Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett’s esophagus", Gastroenterology, 142, pp.233~240 (2012)
  51. Rastogi A, "Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis", Gastrointest Endosc, 67, pp.394~398 (2008)
  52. Shaheen NJ, "Radiofrequency ablation in Barrett’s esophagus with dysplasia", N Engl J Med, 360, pp.2277~2288 (2009)
  53. Park CH, "Proposal of a screening program for gastric cancer in Korea", J Korean Med Assoc, 45, pp.964~971 (2002)
  54. Cho E, "Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea", Asian Pac J Cancer Prev, 14, pp.2533~2540 (2013)
  55. Benaglia T, "Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett’s esophagus", Gastroenterology, 144, pp.62~73 (2013)
  56. American Gastroenterological Association, "American Gastroenterological Association medical position statement on the management of Barrett’s esophagus", Gastroenterology, 140, pp.1084~1091 (2011)
  57. Rubenstein JH, "Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux", Aliment Pharmacol Ther, 32, pp.1222~1227 (2010)
  58. Rubenstein JH, "Prediction of Barrett’s esophagus among men", Am J Gastroenterol, 108, pp.353~362 (2013)
  59. Thrift AP, "Age at onset of GERD symptoms predicts risk of Barrett’s esophagus", Am J Gastroenterol, 108, pp.915~922 (2013)
  60. Jobe BA, "Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett’s esophagus: a randomized and blinded comparison", Am J Gastroenterol, 101, pp.2693~2703 (2006)
  61. Bhardwaj A, "A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett’s esophagus in patients with gastroesophageal reflux disease", Am J Gastroenterol, 104, pp.1533~1539 (2009)
  62. Lao-Sirieix P, "Non-endoscopic screening biomarkers for Barrett’s oesophagus: from microarray analysis to the clinic", Gut, 58, pp.1451~1459 (2009)
  63. Shaheen NJ, "Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians", Ann Intern Med, 157, pp.808~816 (2012)
  64. ASGE Standards of Practice Committee, "The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus", Gastrointest Endosc, 76, pp.1087~1094 (2012)

관련 논문AI추천

Barrett’s Esophagus and Cancer Risk: How Research Advances Can Impact Clinical PracticeDurayd Alzoubaidi, Massimiliano di Pietro, Rebecca C. Fitzgerald거트앤리버 소화기연관학회협의회 · Gut and Liver2014 · 제8권 제4호Quality Indicators in Barrett’s Esophagus: Time to Change the Status QuoSachin Wani, Samuel Han대한소화기내시경학회 · Clinical Endoscopy2018 · 제51권 제4호Barrett's Esophagus: Diagnosis, Screening, Surveillance, and ControversiesRajvinder Singh거트앤리버 소화기연관학회협의회 · Gut and Liver2007 · 제1권 제2호Risk of Barrett’s esophagus progression to esophageal adenocarcinomaAmy Tyberg, Lahari Kota대한소화기내시경학회 · Clinical Endoscopy2024 · 제57권 제6호Advanced endoscopic imaging for detection of Barrett’s esophagusIrving Waxman, Michelle Godbee, Neal A. Mehta, Netanel Zilberstein대한소화기내시경학회 · Clinical Endoscopy2024 · 제57권 제1호Endoscopic Imaging in Barrett’s Oesophagus: Applications in Routine Clinical Practice and Future OutlookRajvinder Singh, Sam Costello대한소화기내시경학회 · Clinical Endoscopy2011 · 제44권 제2호

이 간행물의 다른 논문 (11건)

Interobserver Agreement in Using Magnifying Narrow Band Imaging SystemIl Ju Choipp. 1-2Rectal Retroflexion during Colonoscopy: A Bridge over Troubled Water권광안, 함기백pp. 3-4Barrett Esophagus in Asia: Same Disease with Different Pattern이현석, 전성우pp. 15-22Histopathology in Barrett Esophagus and Barrett Esophagus-Related DysplasiaAndrea Grin, Catherine J. Streutkerpp. 31-39Observer Variability in Gastric Neoplasm Assessment Using the Vessel Plus Surface Classification for Magnifying Endoscopy with Narrow Band ImagingChan Hui Yoo, Do Hyun Kim, 박선자, 문원, 박무인, Jun Young Song, Hyung Hun Kimpp. 74-78
원문 보기